{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:24Z","timestamp":1780426884969,"version":"3.54.1"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Scientific Research Project of the Department of Education of Jilin Province, China","award":["Grant Nos. JJKH20250829KJ"],"award-info":[{"award-number":["Grant Nos. JJKH20250829KJ"]}]},{"name":"Scientific Research Project of the Department of Education of Jilin Province, China","award":["JJKH20200066KJ"],"award-info":[{"award-number":["JJKH20200066KJ"]}]},{"name":"the Higher Education Teaching Reform Research Project of Jilin Province, China","award":["Grant No. SJYB20250012"],"award-info":[{"award-number":["Grant No. SJYB20250012"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    The treatment of gout remains a huge challenge, and currently, the mainstream Western medicine treatment methods still have some drawbacks. This study aims to elucidate the potential mechanism of modified Simiao decoction (MSMD) in the treatment of gout through network pharmacology analysis, Mendelian randomization (MR), and molecular docking. We hope to contribute to the research on the targets of action of traditional Chinese medicine and the exploration of the mechanism of gout. We employed network pharmacology to screen the potential targets of MSMD in relation to gout. MR was utilized to further augment the potential targets and elucidate the causal associations between them and gout. Eventually, the identified targets were combined with active ingredients for the purpose of molecular docking. Through network pharmacology, we identified 44 potential targets. MR analysis identified 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) as a potential causal risk factor for gout (odds ratio [95% confidence interval]\u2005=\u20051.192 [1.033\u20131.375],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.016). Molecular docking predicted that TP53, IL6, TNF, peroxisome proliferator-activated receptor \u03b3, IL1B, and HMGCR exhibited favorable binding effects with the active ingredients. TP53, IL6, TNF, peroxisome proliferator-activated receptor \u03b3, and IL1B are central inflammatory targets of MSMD. Notably, HMGCR was identified as a causal risk factor for gout and a potential target of MSMD. We hypothesize that MSMD may exert therapeutic effects by inhibiting HMGCR activity, counteracting its risk effect. This hypothesis, along with the anti-inflammatory roles of other targets, warrants further experimental validation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044737","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:02:36Z","timestamp":1759248156000},"page":"e44737","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism research on the treatment of gout with modified Simiao decoction based on network pharmacology and Mendelian randomization method"],"prefix":"10.1097","volume":"104","author":[{"given":"Jiaqi","family":"Guo","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Beihua University, Beihua University, Jilin, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Guan","sequence":"additional","affiliation":[{"name":"Gastrointestinal surgery Department, Tonghua Central Hospital, Tonghua, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Liang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Beihua University, Beihua University, Jilin, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Gao","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Beihua University, Beihua University, Jilin, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4824-3931","authenticated-orcid":false,"given":"Liyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Beihua University, Beihua University, Jilin, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Jilin Medical University, Jilin, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout.","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2023.10.030","article-title":"Hyperuricemia and gout reduction by SGLT2 inhibitors in diabetes and heart failure: JACC review topic of the week.","volume":"83","author":"Packer","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.kint.2024.05.033","article-title":"Controversies and practical management of patients with gout and chronic kidney disease.","volume":"106","author":"Johnson","year":"2024","journal-title":"Kidney Int"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.","volume":"6","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"q514","DOI":"10.1136\/bmj.q514","article-title":"How common are side effects of treatment to prevent gout flares when starting allopurinol?","volume":"384","author":"Saul","year":"2024","journal-title":"BMJ"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout.","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1053\/j.ajkd.2024.04.017","article-title":"Efficacy and safety of allopurinol and febuxostat in patients with gout and CKD: subgroup analysis of the STOP gout trial.","volume":"84","author":"Helget","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/M23-0289","article-title":"Association of low-dose colchicine with incidence of knee and hip replacements: exploratory analyses from a randomized, controlled, double-blind trial.","volume":"176","author":"Heijman","year":"2023","journal-title":"Ann Intern Med"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"1275974","DOI":"10.3389\/fphar.2023.1275974","article-title":"TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter.","volume":"14","author":"Sun","year":"2023","journal-title":"Front Pharmacol"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11655-019-3058-y","article-title":"Progress in treatment of gout using Chinese and Western medicine.","volume":"26","author":"Wang","year":"2020","journal-title":"Chin J Integr Med"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jpp\/rgac024","article-title":"Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.","volume":"74","author":"Liu","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jep.2013.10.023","article-title":"Suppressive effect of modified Simiaowan on experimental gouty arthritis: an in vivo and in vitro study.","volume":"150","author":"Shi","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2015.03.035","article-title":"A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout.","volume":"168","author":"Zhao","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/10717544.2018.1431980","article-title":"Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine.","volume":"25","author":"Zheng","year":"2018","journal-title":"Drug Deliv"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12906-022-03622-0","article-title":"Network pharmacology and in vivo experiments reveal the pharmacological effects and molecular mechanisms of Simiao Powder in prevention and treatment for gout.","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms.","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"bbad518","DOI":"10.1093\/bib\/bbad518","article-title":"Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine.","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief Bioinform"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12916-024-03607-5","article-title":"Addressing the credibility crisis in Mendelian randomization.","volume":"22","author":"Burgess","year":"2024","journal-title":"BMC Med"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajhg.2022.12.017","article-title":"Using genetic association data to guide drug discovery and development: review of methods and applications.","volume":"110","author":"Burgess","year":"2023","journal-title":"Am J Hum Genet"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12916-024-03700-9","article-title":"Common pitfalls in drug target Mendelian randomization and how to avoid them.","volume":"22","author":"Gill","year":"2024","journal-title":"BMC Med"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"1404123","DOI":"10.3389\/fnut.2024.1404123","article-title":"Renshen Yangrong decoction for secondary malaise and fatigue: network pharmacology and Mendelian randomization study.","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1570163815666180219112421","article-title":"Molecular docking in formulation and development.","volume":"16","author":"Kaur","year":"2019","journal-title":"Curr Drug Discov Technol"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"e37584","DOI":"10.1016\/j.heliyon.2024.e37584","article-title":"Network pharmacology and bioinformatics approach to unravel the mechanism of Xiao-chai-hu-tang herbal formula in tinnitus treatment.","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023.","volume":"51","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","article-title":"MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search.","volume":"45","author":"Rappaport","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks.","volume":"127","author":"Tang","year":"2015","journal-title":"Biosystems"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression.","volume":"53","author":"Vosa","year":"2021","journal-title":"Nat Genet"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development.","volume":"9","author":"Finan","year":"2017","journal-title":"Sci Transl Med"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease.","volume":"94","author":"Su","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R36-20260602","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R37-20260602","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R38-20260602","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization.","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"R39-20260602","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","article-title":"PubChem BioAssay: 2017 update.","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R40-20260602","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank.","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R41-20260602","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41418-022-00989-y","article-title":"Mutant p53: it\u2019s not all one and the same.","volume":"29","author":"Kennedy","year":"2022","journal-title":"Cell Death Differ"},{"key":"R42-20260602","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery.","volume":"20","author":"Levine","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R43-20260602","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1631\/jzus.B2000446","article-title":"Hydroxychavicol, a polyphenol from Piper betle leaf extract, induces cell cycle arrest and apoptosis in TP53-resistant HT-29 colon cancer cells.","volume":"22","author":"Rajedadram","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"R44-20260602","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/cpsc.102","article-title":"Efficient modulation of TP53 expression in human induced pluripotent stem cells.","volume":"52","author":"Uhlmann","year":"2020","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"R45-20260602","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","article-title":"Clinical value of blocking IL-6 receptor.","volume":"21","author":"Mima","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"R46-20260602","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.bor.0000218949.19860.d1","article-title":"Interleukin-6 in rheumatoid arthritis.","volume":"18","author":"Nishimoto","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R47-20260602","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology.","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"R48-20260602","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri1148","article-title":"Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?","volume":"3","author":"Croft","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R49-20260602","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00011-013-0633-0","article-title":"TNF-alpha signalling and inflammation: interactions between old acquaintances.","volume":"62","author":"Zelova","year":"2013","journal-title":"Inflamm Res"},{"key":"R50-20260602","doi-asserted-by":"crossref","first-page":"637415","DOI":"10.3389\/fphar.2021.637415","article-title":"MicroRNA-223 suppresses IL-1beta and TNF-alpha production in gouty inflammation by targeting the NLRP3 inflammasome.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R51-20260602","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10753-015-0272-4","article-title":"Protective effect of astragaloside IV against paraquat-induced lung injury in mice by suppressing rho signaling.","volume":"39","author":"Chen","year":"2016","journal-title":"Inflammation"},{"key":"R52-20260602","doi-asserted-by":"crossref","first-page":"103214","DOI":"10.1016\/j.jaut.2024.103214","article-title":"PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis.","volume":"146","author":"Geng","year":"2024","journal-title":"J Autoimmun"},{"key":"R53-20260602","doi-asserted-by":"crossref","first-page":"11955","DOI":"10.3390\/ijms241511955","article-title":"PPARG: a novel target for yellow tea in kidney stone prevention.","volume":"24","author":"Su","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R54-20260602","doi-asserted-by":"crossref","first-page":"e20190347","DOI":"10.1084\/jem.20190347","article-title":"Historical overview of the interleukin-6 family cytokine.","volume":"217","author":"Kang","year":"2020","journal-title":"J Exp Med"},{"key":"R55-20260602","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41569-020-0431-7","article-title":"Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6.","volume":"18","author":"Tyrrell","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R56-20260602","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41569-021-00575-8","article-title":"Promising anti-IL-6 therapy for atherosclerosis.","volume":"18","author":"Fernandez-Ruiz","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R57-20260602","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout.","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"R58-20260602","doi-asserted-by":"crossref","first-page":"103468","DOI":"10.1016\/j.autrev.2023.103468","article-title":"Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues.","volume":"22","author":"Khoo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R59-20260602","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.41245","article-title":"Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis.","volume":"72","author":"Yang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R60-20260602","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/imr.12833","article-title":"Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia.","volume":"294","author":"Cabau","year":"2020","journal-title":"Immunol Rev"},{"key":"R61-20260602","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.plaphy.2021.05.023","article-title":"The role of quercetin in plants.","volume":"166","author":"Singh","year":"2021","journal-title":"Plant Physiol Biochem"},{"key":"R62-20260602","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, inflammation and immunity.","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:43Z","timestamp":1780423303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":62,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044737","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-06-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}